BOSTON SCIENTIFIC CORPORATION Restructuring and Related Cost, Incurred Cost
BOSTON SCIENTIFIC CORPORATION (BSX) reported Restructuring and Related Cost, Incurred Cost of $96.00 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringAndRelatedCostIncurredCost · last filed 2020-02-25
- BOSTON SCIENTIFIC CORPORATION restructuring and related cost, incurred cost for the quarter ending 2018-12-31 was $38.00M, a 11.76% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION restructuring and related cost, incurred cost for the quarter ending 2018-09-30 was $15.00M, a 42.31% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION restructuring and related cost, incurred cost for the quarter ending 2018-06-30 was $15.00M, a 6.25% decline year-over-year.
- BOSTON SCIENTIFIC CORPORATION restructuring and related cost, incurred cost for the quarter ending 2018-03-31 was $28.00M, a 47.37% increase year-over-year.
- BOSTON SCIENTIFIC CORPORATION restructuring and related cost, incurred cost for fiscal 2018 was $96.00M, a 1.05% increase from fiscal 2017.
- BOSTON SCIENTIFIC CORPORATION restructuring and related cost, incurred cost for fiscal 2017 was $95.00M, a 21.79% increase from fiscal 2016.
- BOSTON SCIENTIFIC CORPORATION restructuring and related cost, incurred cost for fiscal 2016 was $78.00M, a 6.02% decline from fiscal 2015.
- BOSTON SCIENTIFIC CORPORATION restructuring and related cost, incurred cost for fiscal 2015 was $83.00M, a 29.06% decline from fiscal 2014.
| Period end | Restructuring and Related Cost, Incurred Cost 3 month | Restructuring and Related Cost, Incurred Cost 6 month | Restructuring and Related Cost, Incurred Cost 9 month | Restructuring and Related Cost, Incurred Cost 12 month |
|---|---|---|---|---|
| 2018-12-31 | $38.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $53.00M derived: sum of 2 quarters · filed 2020-02-25 | $68.00M derived: sum of 3 quarters · filed 2020-02-25 | $96.00M 10-K · filed 2020-02-25 |
| 2018-09-30 | $15.00M 10-Q · filed 2018-10-29 | $30.00M derived: sum of 2 quarters · filed 2018-10-29 | $58.00M 10-Q · filed 2018-10-29 | $92.00M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $15.00M 10-Q · filed 2018-07-31 | $43.00M 10-Q · filed 2018-07-31 | $77.00M derived: sum of 3 quarters · filed 2020-02-25 | $103.00M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $28.00M 10-Q · filed 2018-05-01 | $62.00M derived: sum of 2 quarters · filed 2020-02-25 | $88.00M derived: sum of 3 quarters · filed 2020-02-25 | $104.00M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $34.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $60.00M derived: sum of 2 quarters · filed 2020-02-25 | $76.00M derived: sum of 3 quarters · filed 2020-02-25 | $95.00M 10-K · filed 2020-02-25 |
| 2017-09-30 | $26.00M 10-Q · filed 2018-10-29 | $42.00M derived: sum of 2 quarters · filed 2018-10-29 | $61.00M 10-Q · filed 2018-10-29 | $84.00M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | $16.00M 10-Q · filed 2018-07-31 | $35.00M 10-Q · filed 2018-07-31 | $58.00M derived: sum of 3 quarters · filed 2019-02-19 | $75.00M derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | $19.00M 10-Q · filed 2018-05-01 | $42.00M derived: sum of 2 quarters · filed 2019-02-19 | $59.00M derived: sum of 3 quarters · filed 2019-02-19 | $85.00M derived: sum of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | $23.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $40.00M derived: sum of 2 quarters · filed 2019-02-19 | $66.00M derived: sum of 3 quarters · filed 2019-02-19 | $78.00M 10-K · filed 2019-02-19 |
| 2016-09-30 | $17.00M 10-Q · filed 2017-11-02 | $43.00M derived: sum of 2 quarters · filed 2017-11-02 | $55.00M 10-Q · filed 2017-11-02 | $81.00M derived: sum of 4 quarters · filed 2018-02-20 |
| 2016-06-30 | $26.00M 10-Q · filed 2017-08-03 | $39.00M 10-Q · filed 2017-08-03 | $64.00M derived: sum of 3 quarters · filed 2018-02-20 | $85.00M derived: sum of 4 quarters · filed 2018-02-20 |
| 2016-03-31 | $13.00M 10-Q · filed 2017-05-03 | $38.00M derived: sum of 2 quarters · filed 2018-02-20 | $59.00M derived: sum of 3 quarters · filed 2018-02-20 | $74.00M derived: sum of 4 quarters · filed 2018-02-20 |
| 2015-12-31 | $25.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20 | $46.00M derived: sum of 2 quarters · filed 2018-02-20 | $61.00M derived: sum of 3 quarters · filed 2018-02-20 | $83.00M 10-K · filed 2018-02-20 |
| 2015-09-30 | $21.00M 10-Q · filed 2016-11-03 | $36.00M derived: sum of 2 quarters · filed 2016-11-03 | $58.00M 10-Q · filed 2016-11-03 | $105.00M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $15.00M 10-Q · filed 2016-08-03 | $37.00M 10-Q · filed 2016-08-03 | $84.00M derived: sum of 3 quarters · filed 2017-02-23 | $101.00M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $22.00M 10-Q · filed 2016-05-04 | $69.00M derived: sum of 2 quarters · filed 2017-02-23 | $86.00M derived: sum of 3 quarters · filed 2017-02-23 | $111.00M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $64.00M derived: sum of 2 quarters · filed 2017-02-23 | $89.00M derived: sum of 3 quarters · filed 2017-02-23 | $117.00M 10-K · filed 2017-02-23 |
| 2014-09-30 | $17.00M 10-Q · filed 2015-11-04 | $42.00M derived: sum of 2 quarters · filed 2015-11-04 | $70.00M 10-Q · filed 2015-11-04 | $123.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-06-30 | $25.00M 10-Q · filed 2015-08-06 | $53.00M 10-Q · filed 2015-08-06 | $106.00M derived: sum of 3 quarters · filed 2016-02-24 | $132.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2014-03-31 | $28.00M 10-Q · filed 2015-05-06 | $81.00M derived: sum of 2 quarters · filed 2016-02-24 | $107.00M derived: sum of 3 quarters · filed 2016-02-24 | $138.00M derived: sum of 4 quarters · filed 2016-02-24 |
| 2013-12-31 | $53.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | $79.00M derived: sum of 2 quarters · filed 2016-02-24 | $110.00M derived: sum of 3 quarters · filed 2016-02-24 | $124.00M 10-K · filed 2016-02-24 |
| 2013-09-30 | $26.00M 10-Q · filed 2014-11-05 | $57.00M derived: sum of 2 quarters · filed 2014-11-05 | $71.00M 10-Q · filed 2014-11-05 | $124.00M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-06-30 | $31.00M 10-Q · filed 2014-08-06 | $46.00M 10-Q · filed 2014-08-06 | $98.00M derived: sum of 3 quarters · filed 2015-02-25 | $156.00M derived: sum of 4 quarters · filed 2015-02-25 |
| 2013-03-31 | $15.00M 10-Q · filed 2014-05-08 | $67.00M derived: sum of 2 quarters · filed 2015-02-25 | $125.00M derived: sum of 3 quarters · filed 2015-02-25 | $158.00M derived: sum of 4 quarters · filed 2015-02-25 |
| 2012-12-31 | $52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $110.00M derived: sum of 2 quarters · filed 2015-02-25 | $143.00M derived: sum of 3 quarters · filed 2015-02-25 | $160.00M 10-K · filed 2015-02-25 |
| 2012-09-30 | $58.00M 10-Q · filed 2013-11-05 | $91.00M derived: sum of 2 quarters · filed 2013-11-05 | $108.00M 10-Q · filed 2013-11-05 | |
| 2012-06-30 | $33.00M 10-Q · filed 2013-08-07 | $50.00M 10-Q · filed 2013-08-07 | ||
| 2012-03-31 | $17.00M 10-Q · filed 2013-05-07 | |||
| 2011-09-30 | $29.00M 10-Q · filed 2012-11-06 | $59.00M derived: sum of 2 quarters · filed 2012-11-06 | $109.00M 10-Q · filed 2012-11-06 | |
| 2011-06-30 | $30.00M 10-Q · filed 2012-08-07 | $80.00M 10-Q · filed 2012-08-07 | ||
| 2011-03-31 | $50.00M 10-Q · filed 2012-05-03 | |||
| 2010-09-30 | $18.00M 10-Q · filed 2011-11-08 | $59.00M derived: sum of 2 quarters · filed 2011-11-08 | $139.00M 10-Q · filed 2011-11-08 | |
| 2010-06-30 | $41.00M 10-Q · filed 2011-08-05 | $121.00M 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |